The present invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for stimulating or enhancing the development, mobilization, proliferation and/or differentiation of a neutrophil-containing leukocyte population that inhibits growth and/or spread of a tumor and for treating or preventing a hyperproliferative cell disorder.
[EN] ARYL SUBSTITUTED IMIDAZO [4,5-C] PYRIDINE COMPOUNDS AS C3A RECEPTOR ANTAGONISTS<br/>[FR] COMPOSÉS DE TYPE IMIDAZO[4,5-C]PYRIDINE ARYLSUBSTITUÉS EN TANT QU'ANTAGONISTES DU RÉCEPTEUR C3A
申请人:PFIZER PROD INC
公开号:WO2007034277A1
公开(公告)日:2007-03-29
[EN] Aryl substituted imidazo[4,5-c] pyridine compounds of formula (I) or pharmaceutically acceptable salt thereof are provided. These compounds are useful in pharmaceutical compositions as C3a antagonists for treating a variety of medical conditions associated with the Complement cascade. [FR] La présente invention concerne des composés de type imidazo[4,5-c]pyridine arylsubstitués de formule (I) ou leurs sels de qualité pharmaceutique. Ces dérivés peuvent être employés dans des préparations pharmaceutiques en tant qu'antagonistes de C3a pour le traitement d'une multitude d'états pathologiques associés à la cascade du complément.
[EN] MOBILIZING AGENTS AND USES THEREFOR<br/>[FR] AGENTS MOBILISATEURS ET LEURS UTILISATIONS
申请人:UNIV QUEENSLAND
公开号:WO2016191811A1
公开(公告)日:2016-12-08
The present invention discloses the use of a complement 3a receptor (C3aR) antagonist and a mobilizer of hematopoietic stem cells and/or progenitor cells in methods and compositions for stimulating or enhancing the development, mobilization, proliferation and/or differentiation of a neutrophil-containing leukocyte population that inhibits growth and/or spread of a tumor and for treating or preventing a hyperproliferative cell disorder.